Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”. J. Can. Res. Updates [Internet]. 2026 Jun. 9 [cited 2026 Jun. 10];15(1):150-5. Available from: https://mail.neoplasiaresearch.com/index.php/jcru/article/view/960